13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

Page 12 of 12

Page 12 of 12 – SEC Filing

Schedule II
The business and operations of OrbiMed Capital GP III LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I.

Follow Palvella Therapeutics Inc. (NYSE:PVLA)

Page 12 of 12